Parameters | Placebo (N = 13) | Ezetimibe (N = 10) | Xuezhikang (N = 10) | Xuezhikang + ezetimibe (N = 10) | Pitavstatin (N = 10) | Pitavstatin + ezetimibe (N = 10) |
---|---|---|---|---|---|---|
PCSK9 ng/ml | 296.29 ± 112.95 | 664.76 ± 331.73* | 461.20 ± 124.96* | 482.86 ± 130.29* | 626.16 ± 221.48* | 901.35 ± 235.56*#Δ |
TG mmol/l | 0.76 ± 0.72 | 0.51 ± 0.17 | 1.38 ± 0.12 | 1.26 ± 0.29 | 0.44 ± 0.12 | 0.91 ± 0.18 |
TC mmol/l | 2.13 ± 0.26 | 2.44 ± 0.40 | 2.25 ± 0.37 | 2.19 ± 0.40 | 2.50 ± 0.40 | 2.39 ± 0.33 |
HDL-C mmol/l | 1.04 ± 0.29 | 1.31 ± 0.29 | 1.04 ± 0.29 | 0.94 ± 0.20 | 1.25 ± 0.27 | 1.22 ± 0.27 |
LDL-C mmol/l | 0.53 ± 0.14 | 0.51 ± 0.15 | 0.45 ± 0.07 | 0.42 ± 0.04 | 0.64 ± 0.18 | 0.48 ± 0.09 |